COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases.

Seyed Ali Moosavi Amirali Mashhadiagha Nasrin MotazedianAlireza HashemazarAmir Human HoveidaeiDavide Bolignano

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

Patients' demographics, signs, symptoms, and radiographic findings in SOT recipients are almost similar to the general population. However, gastrointestinal symptoms appear to be more common. There are different treatment strategies, but in most of them, antimetabolite and calcineurin inhibitors were decreased or discontinued, while corticosteroids were increased. Finally, COVID-19 seems to be more severe and has higher mortality in SOT recipients compared to the general population.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
early onset
type diabetes
risk factors
cardiovascular disease